Translational lung cancer research · 2024
Analysis of the lymph node metastasis distribution in patients with invasive resectable non-small cell lung cancer.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xu Congcong, Sun Jiajing, Liu Hao, Chen Baofu, Wu Sikai, Qiu Hongbin, Li Jiawei, Chen Dong, Zhu Kanghao, Jin Zixian, Zhang Jian, Zhang Bo, Chen Zhongxiao, Witharana Pasan, Cho William C, Shen Jianfei
Аннотация
BACKGROUND: The current standard for the surgical management of lung cancer involves anatomic lung resection combined with systemic lymph node dissection/sampling. The purpose of this study was to investigate the patterns of pathological lymph nodes in invasive non-small cell lung cancer (NSCLC), explore the occurrence in lymph node metastasis (LNM), and provide recommendations for optimal lymph node resection/sampling in lung cancer operation.
METHODS: There were 1,678 patients with NSCLC who underwent lobectomy between 2018 and 2021 at the Taizhou Hospital of Zhejiang Province were reviewed retrospectively. The location and incidence of LNM and postoperative pathological findings were studied. We analysed the metastasis rates of lymph node dissection stations using Pearson's χ2 and Fisher's exact tests.
RESULTS: There were 1,308 patients assessed as eligible and included in the study. The median number of lymph nodes cleared in the cohort was 11.2±5.1. In patients with lung adenocarcinoma, the rate of LNM was significantly higher in central than in peripheral lung cancer, especially in 2R/2L, L7, L9, L10, L11, and L12. Lung cancer patients with tumors ≤1 cm had no N2 lymph node metastases but few (2/191, 1.1%) N1 lymph node metastases. The likelihood of N2 metastasis increased (T1a, 0%, 0/191; T1b 3.5%, 22/625; T1c, 5.6%, 14/249; T2 and above, 18.9%, 46/243) with increasing tumor diameter. Thirty-four patients with stage N2 lung adenocarcinoma and 1-3 cm tumors displayed lobe-specific lymph node metastases in the mediastinum. In patients diagnosed with squamous cell carcinoma, no significant differences were observed in mediastinal LNM across various parameters (central versus peripheral location, tumor site, and tumor size).
CONCLUSIONS: Our study proposes recommendations for lymph node resection according to the pathological type of lung cancer, tumor location, lung lobes affected and tumor size, which may provide a certain reference value for the clinical work.
METHODS: There were 1,678 patients with NSCLC who underwent lobectomy between 2018 and 2021 at the Taizhou Hospital of Zhejiang Province were reviewed retrospectively. The location and incidence of LNM and postoperative pathological findings were studied. We analysed the metastasis rates of lymph node dissection stations using Pearson's χ2 and Fisher's exact tests.
RESULTS: There were 1,308 patients assessed as eligible and included in the study. The median number of lymph nodes cleared in the cohort was 11.2±5.1. In patients with lung adenocarcinoma, the rate of LNM was significantly higher in central than in peripheral lung cancer, especially in 2R/2L, L7, L9, L10, L11, and L12. Lung cancer patients with tumors ≤1 cm had no N2 lymph node metastases but few (2/191, 1.1%) N1 lymph node metastases. The likelihood of N2 metastasis increased (T1a, 0%, 0/191; T1b 3.5%, 22/625; T1c, 5.6%, 14/249; T2 and above, 18.9%, 46/243) with increasing tumor diameter. Thirty-four patients with stage N2 lung adenocarcinoma and 1-3 cm tumors displayed lobe-specific lymph node metastases in the mediastinum. In patients diagnosed with squamous cell carcinoma, no significant differences were observed in mediastinal LNM across various parameters (central versus peripheral location, tumor site, and tumor size).
CONCLUSIONS: Our study proposes recommendations for lymph node resection according to the pathological type of lung cancer, tumor location, lung lobes affected and tumor size, which may provide a certain reference value for the clinical work.